BeyondSpring, Inc. (BYSI)
0.4311
-0.01
(-3.15%)
USD |
NASDAQ |
Oct 23, 16:00
0.4376
+0.01
(+1.51%)
After-Hours: 20:00
BeyondSpring Enterprise Value : 10.91M for Oct. 23, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 10.91M |
| October 22, 2026 | 11.49M |
| October 21, 2026 | 13.57M |
| October 20, 2026 | 14.68M |
| October 19, 2026 | 14.27M |
| October 16, 2026 | 16.18M |
| October 15, 2026 | 17.11M |
| October 14, 2026 | 17.32M |
| October 13, 2026 | 18.13M |
| October 12, 2026 | 18.49M |
| October 09, 2026 | 18.09M |
| October 08, 2026 | 18.22M |
| October 07, 2026 | 19.68M |
| October 06, 2026 | 21.65M |
| October 05, 2026 | 25.50M |
| October 02, 2026 | 25.56M |
| October 01, 2026 | 26.64M |
| September 30, 2026 | 24.85M |
| September 29, 2026 | 24.98M |
| September 28, 2026 | 39.24M |
| September 25, 2026 | 25.14M |
| September 24, 2026 | 22.99M |
| September 23, 2026 | 23.06M |
| September 22, 2026 | 23.62M |
| September 21, 2026 | 23.61M |
| Date | Value |
|---|---|
| September 18, 2026 | 24.01M |
| September 17, 2026 | 22.33M |
| September 16, 2026 | 22.33M |
| September 15, 2026 | 24.04M |
| September 14, 2026 | 24.43M |
| September 11, 2026 | 24.60M |
| September 10, 2026 | 24.71M |
| September 09, 2026 | 19.04M |
| September 08, 2026 | 18.69M |
| September 04, 2026 | 18.60M |
| September 03, 2026 | 18.77M |
| September 02, 2026 | 18.31M |
| September 01, 2026 | 17.96M |
| August 31, 2026 | 18.70M |
| August 28, 2026 | 20.54M |
| August 27, 2026 | 19.51M |
| August 26, 2026 | 21.56M |
| August 25, 2026 | 22.80M |
| August 24, 2026 | 22.35M |
| August 21, 2026 | 22.79M |
| August 20, 2026 | 22.79M |
| August 19, 2026 | 22.87M |
| August 18, 2026 | 22.71M |
| August 17, 2026 | 22.44M |
| August 14, 2026 | 27.69M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.514B |
| Alnylam Pharmaceuticals, Inc. | 29.64B |
| Anika Therapeutics, Inc. | 273.50M |
| Savara, Inc. | 724.16M |
| Vericel Corp. | 2.108B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.75M |
| Total Expenses (Quarterly) | 0.909M |
| EPS Diluted (Quarterly) | -0.0206 |
| Earnings Yield | -38.02% |
| Normalized Earnings Yield | -38.02 |